5th TIL Therapies Summit 2023

Join us at the 5th TIL Therapies Summit, where groundbreaking advancements in TIL (Tumor-Infiltrating Lymphocytes) therapy are set to revolutionize the field of cancer treatment. Hosted by industry leaders such as Iovance Biotherapeutics, Turnstone Biologics, Achilles Therapeutics, and Lyell Immunopharma, this exclusive event is the premier forum for addressing the key challenges in the end-to-end development of TIL therapies, from initial discovery to commercialization.

At the summit, you will have the opportunity to unite with renowned TIL experts from both industry and academia, as they share their latest clinical updates, next-generation engineering techniques, and novel innovations. With over 23 expert speakers, 75% of whom are new to the event, and the addition of 8 new companies, this year's summit promises a fresh perspective and exciting insights into the field of TIL therapies.

One of the highlights of this year's summit is the introduction of the Manufacturing & Characterization Bootcamp, designed to provide participants with valuable knowledge and practical strategies to enhance the cost-effectiveness and turnaround time of TIL therapy development. This bootcamp will delve into the intricacies of manufacturing and characterization processes, aiming to empower attendees to accelerate the preclinical and clinical development of safe, scalable, and effective TIL therapies.

By attending the 5th TIL Therapies Summit, you will gain unparalleled opportunities to connect and collaborate with a niche community of TIL experts. Whether you are seeking clinical validation, aiming to turbocharge modified therapies, or eager to contribute to the next wave of TIL therapies, this event offers a unique platform for networking and knowledge exchange.

Don't miss this unrivaled opportunity to stay at the forefront of TIL therapy advancements. Secure your spot at the 5th TIL Therapies Summit and be part of the journey to transform cancer treatment and improve patient outcomes.